Search research articles
Contact Us
Filters
Showing results (31-40 of 226) with videos related to
Page
of 23
Sort By:
Progress in Clinical and Biological Research
|
January 1, 1994
Gene marking to improve the outcome of autologous bone marrow transplantation
M K Brenner, D R Rill
Current Opinion in Immunology
|
October 1, 1991
Graft-versus-host reactions and bone-marrow transplantation
M K Brenner, H E Heslop
The New England Journal of Medicine
|
November 3, 1988
Is circulating tumor necrosis factor bioactive?
A S Duncombe, M K Brenner
Current Pharmaceutical Design
|
February 10, 2009
Cellular immunotherapy for neuroblastoma: a review of current vaccine and adoptive T cell therapeutics
C U Louis, M K Brenner
Immunology
|
January 1, 1983
Induction of immunoglobulin and antigen-dependent antibody synthesis in human lymphocytes, using supernatants from mitogen-stimulated cultures
M E North, M K Brenner
Clinical and Experimental Immunology
|
October 1, 1981
Human anti-tetanus antibody response in vitro: autologous and allogeneic T cells provide help by different routes
M K Brenner, A J Munro
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1988
Allogeneic bone marrow transplantation. Recent developments and the potential expansion of the donor pool
H G Prentice, M K Brenner, M McGovern
Bone Marrow Transplantation
|
January 1, 1989
T cell depleted bone marrow transplantation in acute myeloblastic leukaemia: the way ahead
H G Prentice, M K Brenner, D Gottlieb
Medical and Pediatric Oncology
|
December 7, 2000
Selection of human antitumor single-chain Fv antibodies from the B-cell repertoire of patients immunized against autologous neuroblastoma
C Rossig, J G Nuchtern, M K Brenner
Hematology/Oncology Clinics of North America
|
April 30, 1998
Controversies and new approaches to treatment of Langerhans cell histiocytosis
R J Arceci, M K Brenner, J Pritchard
Page
of 23
Search research articles
Search
Showing results (31-40 of 226) with videos related to
Sort By:
Page
of 23
Progress in Clinical and Biological Research
|
January 1, 1994
Gene marking to improve the outcome of autologous bone marrow transplantation
M K Brenner, D R Rill
Current Opinion in Immunology
|
October 1, 1991
Graft-versus-host reactions and bone-marrow transplantation
M K Brenner, H E Heslop
The New England Journal of Medicine
|
November 3, 1988
Is circulating tumor necrosis factor bioactive?
A S Duncombe, M K Brenner
Current Pharmaceutical Design
|
February 10, 2009
Cellular immunotherapy for neuroblastoma: a review of current vaccine and adoptive T cell therapeutics
C U Louis, M K Brenner
Immunology
|
January 1, 1983
Induction of immunoglobulin and antigen-dependent antibody synthesis in human lymphocytes, using supernatants from mitogen-stimulated cultures
M E North, M K Brenner
Clinical and Experimental Immunology
|
October 1, 1981
Human anti-tetanus antibody response in vitro: autologous and allogeneic T cells provide help by different routes
M K Brenner, A J Munro
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1988
Allogeneic bone marrow transplantation. Recent developments and the potential expansion of the donor pool
H G Prentice, M K Brenner, M McGovern
Bone Marrow Transplantation
|
January 1, 1989
T cell depleted bone marrow transplantation in acute myeloblastic leukaemia: the way ahead
H G Prentice, M K Brenner, D Gottlieb
Medical and Pediatric Oncology
|
December 7, 2000
Selection of human antitumor single-chain Fv antibodies from the B-cell repertoire of patients immunized against autologous neuroblastoma
C Rossig, J G Nuchtern, M K Brenner
Hematology/Oncology Clinics of North America
|
April 30, 1998
Controversies and new approaches to treatment of Langerhans cell histiocytosis
R J Arceci, M K Brenner, J Pritchard
Page
of 23